Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.

Br J Haematol 2016 Mar 5;172(6):909-13. Epub 2016 Jan 5.

Department of Biomedicine and Prevention, Università di Roma "Tor Vergata", Rome, Italy.

Acute promyelocytic leukaemia (APL) is characterized by the PML/RARA fusion transcript. PML and RARA mutations have been shown to directly respond to arsenic trioxide (ATO) and all-trans retinoic (ATRA). We analysed the prevalence of PML mutations in 32 patients with de novo or therapy-related APL (t-APL; n = 5), treated with ATO. We identified one ATO-resistant t-APL patient, who presented a PML A216T mutation in both the rearranged and unrearranged PML alleles, and two mutations in the rearranged RARA gene. In this patient, subclones with different PML and RARA mutations acquired clonal dominance during the disease course, probably leading to treatment resistance.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13910DOI Listing
March 2016

Publication Analysis

Top Keywords

pml rara
8
rara mutations
8
acute promyelocytic
8
promyelocytic leukaemia
8
unrearranged pml
8
pml alleles
8
mutations rearranged
8
rearranged unrearranged
8
pml
6
mutations
5
treated ato
4
t-apl treated
4
t-apl patient
4
identified ato-resistant
4
ato-resistant t-apl
4
ato identified
4
novo therapy-related
4
prevalence pml
4
analysed prevalence
4
atra analysed
4

Similar Publications